COMMUNIQUÉS West-GlobeNewswire

Expanding retirement security for Ontario’s healthcare workers: HOOPP welcomes 35 new employers to the plan in 2023

30/05/2024 - 14:00

TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- HOOPP was pleased to welcome 35 new employers, including hospices, community care and family health teams, to the Plan in 2023. As one of the strongest, lowest cost and most [...]

INmune Bio Inc. to Join Russell 3000® Index

30/05/2024 - 14:00

Boca Raton, Florida, May 30, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, is set to join the broad-market Russell 3000 ® Index at the [...]

4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis at 47ᵗʰ European Cystic Fibrosis Conference

30/05/2024 - 14:00

Interim clinical data will be presented by Jennifer L. Taylor-Cousar, M.D., Principal Investigator of the AEROW clinical trial at the 47 th European Cystic Fibrosis Conference on Thursday, June 6, 2024 at 5:00 p.m. BST [...]

Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference

30/05/2024 - 14:00

TAMPA, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 [...]

Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference

30/05/2024 - 14:00

SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to [...]

LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference

30/05/2024 - 14:00

SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop [...]

Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference

30/05/2024 - 14:00

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human [...]

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

30/05/2024 - 14:00

DUBLIN, May 30, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will [...]

Prime Medicine to Present at Upcoming Investor Conferences

30/05/2024 - 14:00

CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]

ImCheck to Present Promising ICT01 Data from the EVICTION Study at ASCO 2024

30/05/2024 - 14:00

ImCheck to Present Promising ICT01 Data from the EVICTION Study at ASCO 2024 Interim data from Phase I/II EVICTION study shows favorable safety profile and promising efficacy for ICT01 in combination with pembrolizumab [...]

Humacyte to Present at the Jefferies Global Healthcare Conference

30/05/2024 - 14:00

DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today [...]

New study identifies higher risk of depression and anxiety among young men, gay or bisexual, and racialized Canadian men

30/05/2024 - 14:00

43% of young men aged 19-29 are at risk of depression Moderate-to-high anxiety impacts 57% of young men, 45% of gay or bisexual men, and 42% of racialized men National study from the Canadian Men’s Health Foundation [...]

ORYZON to Provide Corporate Progress Updates at Several Events in June

30/05/2024 - 14:00

BIO International Convention 2024 European Hematology Association (EHA) 2024 European Network to Cure ALS (ENCALS) 2024 MADRID and CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: [...]

Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

30/05/2024 - 14:00

NORWOOD, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide [...]

Rezolute to Participate in the Jefferies Global Healthcare Conference

30/05/2024 - 14:00

REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for [...]

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

30/05/2024 - 12:00

Co-developing immune-evasive allogeneic TCR-iPS-T-cell therapies for the treatment of solid tumors SÖDERTÄLJE, Sweden and SAN FRANCISCO and KYOTO, Japan, May 30, 2024 (GLOBE NEWSWIRE) -- Anocca AB (Anocca), a leading T- [...]

Enterome to Participate in the Jefferies Global Healthcare Conference

30/05/2024 - 12:00

PARIS, May 30, 2024 (GLOBE NEWSWIRE) -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry [...]

ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society

30/05/2024 - 12:00

PLEASANTON, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that it has contributed two scientific abstracts that have [...]

Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy

30/05/2024 - 10:30

Clinical study performed in 2022 now published in peer-reviewed Neurology and Therapy Further elaborates on bioequivalence demonstrated versus European listed drug Dormicum® Early onset can be expected thanks to early [...]